For pediatric patients 1 day to 12 months, what is the nebulized dose of Ipratropium Bromide Inhalation Solution with Albuterol?

• A. 0.25 mg
• B. 0.5 mg
• C. 0.75 mg
• D. 1.0 mg

Answer: (A)

Pediatric dosing for nebulized ipratropium with albuterol is based on age, with infants receiving a smaller amount to achieve bronchodilation while minimizing systemic effects. For infants from birth to 12 months, the standard nebulized ipratropium dose is 0.25 mg per treatment. This dose is appropriate for their smaller airways and greater sensitivity, and it avoids the higher systemic anticholinergic burden that comes with the adult dose. The albuterol component is typically given at 2.5 mg per nebulization, but the question focuses on the ipratropium amount, which is 0.25 mg for this age group. Higher ipratropium doses (such as 0.5 mg, 0.75 mg, or 1.0 mg) are not used in this pediatric population because they do not improve efficacy and increase the risk of adverse effects like tachycardia and dry mouth.